Cost-effectiveness of evolocumab in treatment of heterozygous familial hypercholesterolaemia in Bulgaria: measuring health benefit by effectively treated patient-years*

  1. Borissov, B.
  2. Urbich, M.
  3. Georgieva, B.
  4. Tsenov, S.
  5. Villa, G.
Revue:
Journal of Market Access and Health Policy

ISSN: 2001-6689

Année de publication: 2017

Volumen: 5

Número: 1

Type: Article

DOI: 10.1080/20016689.2017.1412753 GOOGLE SCHOLAR lock_openAccès ouvert editor